Estudo de caso-controle | Efetividade da vacina da Pfizer contra COVID-19 em adolescentes.
25 Mar, 2022 | 14:55hEffectiveness of BNT162b2 against COVID-19 in adolescents – The Lancet Infectious Diseases
Comentário no Twitter
Our paper on #COVID19 vaccine effectiveness in teenagers (12-17y) is published @TheLancetInfDis. Rapid waning of protection against symptomatic disease, esp with omicron. Vaccines did reduce delta hospitalisations but too early to assess omicron effects
— Shamez Ladhani (@ShamezLadhani) March 23, 2022